Latest News

Subscribe to RSS feed Syndicate content
FAMILIAL PF
Study traces family ties of pulmonary fibrosis
ON 2/26/2010

BY: KATHY WHITNEY

2/26/2010 - Ed Dailey flew from Wayne, Pa., to Nashville on a snowy February day to undergo blood work, a CT scan and bronchoscopy at Vanderbilt.

But Dailey is not sick. In fact, there is nothing wrong with him.

READ FULL ARTICLE >
MEDICAL NEWS
Lung Rx and ImmuneWorks Announce Collaboration in IPF and Primary Graft Dysfunction
ON 2/10/2010

Lung Rx, LLC, a wholly-owned subsidiary of United Therapeutics Corporation announced today that it has entered into a Development Agreement with ImmuneWorks, Inc. to pursue development of ImmuneWorks' lead compound, IW001, a purified bovine Type V Collagen oral solution for the treatment of IPF and Primary Graft Dysfunction (PGD) in patients receiving lung transplant.

READ FULL ARTICLE >
MEDICAL NEWS
UPMC Earmarks $350K from NIH Grant for WaferGen Real-Time PCR Studies
ON 2/3/2010

February 3, 2010 - Wafergen Biosystems said this week that researchers at the University of Pittsburgh have earmarked $350,000 from an NIH grant to pay for research that will use Wafergen's SmartChip real-time PCR system as part of a larger multi-institution study on the genomics of chronic lung disease.

Researchers at the University of Pittsburgh Medical Center will use the money primarily to

READ FULL ARTICLE >
MEDICAL NEWS
Lung Rx and mondoBIOTECH Announce Partnership in IPF Research
ON 2/3/2010

SILVER SPRING, Md.

READ FULL ARTICLE >
BREAKTHROUGHS
Test could predict which idiopathic pulmonary fibrosis patients will become severely ill
ON 2/3/2010

February 3, 2010

A simple blood test could predict which patients with the lung-scarring disease known as idiopathic pulmonary fibrosis (IPF) are soon to get far worse, an indicator that could one day influence their treatment, according to researchers at the University of Pittsburgh School of Medicine.

READ FULL ARTICLE >